Time to look again at emerging markets

Emerging Markets

Focus on quality assets in right geographies with real cash flows

Opportunities in flawed private equity

The very best PE firms do us all a favour by building leaner, more competitive businesses

Time for investors to get back into oil

We may have reached the bottom for prices in hard-hit sector

David Stevenson, MFT Byline.
©Charlie Bibby

Financing steps out of the shadows

Royalty structures in various sectors can deliver attractive returns

David Stevenson, MFT Byline.
©Charlie Bibby

Why Smart Beta is big business

This system has found form and shape within ETFs with an utterly confusing array of terms

David Stevenson, MFT Byline.
©Charlie Bibby

Why I’m hanging on to resources stocks

Volatility represents a massive long-term buying opportunity

David Stevenson, MFT Byline.
©Charlie Bibby

Investment ‘brain food’ — an online menu

New sources of data, from niche to mainstream

David Stevenson, MFT Byline.
©Charlie Bibby

A niche sector from the ground up

A riskier replacement for index-linked gilts

David Stevenson, MFT Byline.
©Charlie Bibby

Concern over ‘mainstream’ mini-bonds

Rates are puny — and will you get your money back?

David Stevenson, MFT Byline.
©Charlie Bibby

China’s woes are overplayed — it’s an opportunity

Beijing will not allow growth to flag, boosting the rest of Asia

Frontier markets can reward the specialist

Lack of liquidity need not be a barrier to good returns

Three ideas for juicier yields

Many infrastructure funds are starting to look pricey

Infrastructure route to returns

Europe needs a vast infusion of capital into new roads, schools, airports, energy and housing

Passive bond solutions

Over-concentration is a big problem in bond indices, but some new ETFs have addressed it

Witan actually delivers

Most of its rivals simply stack up fees. This one is different

Help online for DIY investors

Websites to make stockpicking easier for private investors

Oil at issue for retail bonds

Are EnQuest bonds, trading at half their face value, a buy for contrarian investors?

Second time lucky in biotech

Using funds rather than picking stocks has improved my returns

A crowded market, but promising

Crowdfunding remains almost exclusively UK-based

Traded life policies are alive

It is still possible to invest in ‘death futures’, which are usefully uncorrelated to equity returns